Inclusion Criteria : 
  -  Visible index lesion ( s ) on MRI
  -  Index lesion ( s ) greater than  0.5 cm 3
  -  Found to have localized low - risk or intermediate - risk prostate cancer after MRI - USG fusion targeted biopsy and saturation biopsy : 
        1.  Clinical tumour stage T 2 , or
        2.  Gleason score  7 , or
        3.  PSA  20 ng / ml
Exclusion Criteria : 
  -  Prostate size larger than  50 ml
  -  Patients unfit for contrast MRI exam
  -  Patients with previous treatment of prostate cancer
  -  Patients with previous surgery on the prostate
  -  Patients with active urinary tract infection
  -  Patients with bladder pathology including bladder stone and bladder cancer
  -  Patients with urethral stricture
  -  Patients with neurogenic bladder and / or sphincter abnormalities
  -  Fail to give informed consent